Research programme: parathyroid hormone 1 receptor agonists - Septerna
Alternative Names: PTH1R agonists- SepternaLatest Information Update: 03 Oct 2024
Price :
$50 *
At a glance
- Originator Septerna
- Class Small molecules
- Mechanism of Action Parathyroid hormone receptor type 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hypoparathyroidism
Most Recent Events
- 30 Sep 2024 Updated pharmacodynamics data from preclinical studies in Hypoparathyroidism released by Septerna
- 03 Jun 2024 Septerna plans a phase I trial for Hypoparathyroidism (In-volunteers) in late 2024
- 03 Jun 2024 Pharmacodynamics data from preclinical studies in Hypoparathyroidism released by Septerna